Get started
Author

Geneviève Durrieu

Observed names: DURRIEU, Geneviève, Durrieu, Genevieve, G Durrieu, G. DURRIEU, G. Durrieu, Genevieve Durrieu, Geneviéve Durrieu, Genevi�ve Durrieu
Observed institutions: Rutgers, The State University of New Jersey, Université Toulouse III - Paul Sabatier, Inserm, Centre Hospitalier Universitaire de Toulouse, Hospices Civils de Lyon, Hôpital Européen Georges-Pompidou, Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps, Hôpital Purpan, Hôpital Paule de Viguier, Hôpital de La Grave, Centre d’Investigation Clinique 1436, Université de Toulouse
ORCID: 0000-0002-3717-2784
Observed ORCID: 0000-0002-3717-2784
OpenAlex ID: A5036143753
Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
2006 · Jean-Louis Montastruc, Agnès Sommet, et al. · Joint Bone Spine · 124
Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States
2013 · Barbara Mintzes, Joel Lexchin, et al. · Journal of General Internal Medicine · 117
PDF
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
2021 · Anthony Touafchia, Haleh Bagheri, et al. · Clinical Microbiology and Infection · 113
PDF
Pharmacovigilance, risks and adverse effects of self-medication
2016 · Jean-Louis Montastruc, Emmanuelle Bondon-Guitton, et al. · Therapies · 111
Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension
1990 · J. M. SENARD, P. VALET, et al. · European Journal of Clinical Investigation · 102
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database
2021 · Jean‐Louis Montastruc, Margaux Lafaurie, et al. · British Journal of Clinical Pharmacology · 93
Off-Label Prescribing in Pediatric Outpatients
2014 · Aurore Palmaro, Raphael Bissuel, et al. · PEDIATRICS · 87
Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations
2020 · Eloise Baudou, Anne Lespine, et al. · New England Journal of Medicine · 82
PDF
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
2020 · François Montastruc, Samuel Thuriot, et al. · Clinical Gastroenterology and Hepatology · 78
PDF
Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment
1992 · Geneviève Durrieu, Marie-Elise LLau, et al. · Clinical Autonomic Research · 78
A comparative study of QT prolongation with serotonin reuptake inhibitors
2017 · Ana Ojero-Senard, Justine Benevent, et al. · Psychopharmacology · 69
Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database
2007 · G. Durrieu, P. Olivier, et al. · Fundamental and Clinical Pharmacology · 59
Effects of Yohimbine on Plasma Catecholamine Levels in Orthostatic Hypotension Related to Parkinson Disease or Multiple System Atrophy
1993 · J. M. Senard, O. Rascol, et al. · Clinical Neuropharmacology · 59
Off-label and unlicensed drug use in children population
2018 · Florence Moulis, Geneviève Durrieu, et al. · Therapies · 57
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study
2016 · Geneviève Durrieu, Julien Jacquot, et al. · Drug Safety · 56
Adverse drug reactions to self‐medication: a study in a pharmacovigilance database
2015 · Aurélia Berreni, François Montastruc, et al. · Fundamental and Clinical Pharmacology · 50
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study
2013 · Marie‐Laure Laroche, Marie‐Christine Perault‐Pochat, et al. · Pharmacoepidemiology and Drug Safety · 50
Drug interactions between antihypertensive drugs and non‐steroidal anti‐inflammatory agents: a descriptive study using the French Pharmacovigilance database
2012 · Jean‐Pascal Fournier, Agnès Sommet, et al. · Fundamental and Clinical Pharmacology · 47
Trends of reporting of ‘serious’vs. ‘non‐serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
2012 · Guillaume Moulis, Agnès Sommet, et al. · British Journal of Clinical Pharmacology · 47
PDF
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France
2011 · Francois Montastruc, Agnès Sommet, et al. · European Journal of Clinical Pharmacology · 41
Effects of Levodopa and Bromocriptine on Blood Pressure and Plasma Catecholamines in Parkinsonians
1991 · G. Durrieu, J. M. Senard, et al. · Clinical Neuropharmacology · 41
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting
2017 · François Montastruc, Haleh Bagheri, et al. · Drug Safety · 40
A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006
2011 · Agnès Sommet, Genevieve Durrieu, et al. · Pharmacoepidemiology and Drug Safety · 38
Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase
2016 · Jeanne Montastruc, Philippe Marque, et al. · Developmental Medicine & Child Neurology · 31
PDF
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines
2012 · Geneviéve Durrieu, Aurore Palmaro, et al. · Drug Safety · 31
Works count: 160
Citation count: 2,708
H-index: 28
I10-index: 68
Year
Topic
Type